April, 13 2021, 12:00am EDT

On Eve of WTO COVID Meeting: Director General's "Third Way" Is Same Old Way of Big Pharma Control Over COVID Vaccine Supply, Rebranded
The World Trade Organization (WTO) Director General (DG) is holding a "Third Way" COVID-19 vaccine confab in Geneva on April 14th that at best is a distraction from an effective initiative that falls squarely within the WTO's actual remit.
WASHINGTON
The World Trade Organization (WTO) Director General (DG) is holding a "Third Way" COVID-19 vaccine confab in Geneva on April 14th that at best is a distraction from an effective initiative that falls squarely within the WTO's actual remit. That would be a temporary COVID-19 waiver of patent, copyright, industrial design and undisclosed information terms of the WTO Trade Related Aspects of Intellectual Property (TRIPS) agreement, to the extent they hinder the "prevention, treatment and control" of the COVID-19 pandemic.
By design, what the WTO DG has dubbed the "Third Way" is unlikely to help bolster COVID-19 vaccine or treatment supplies because it leaves the same few pharmaceutical firms in total control of supply. Relying on contract manufacturing and voluntary licensing is the approach that has led to massive shortages with a few firms controlling if, where and when supply will be manufactured and can be sold or distributed and at what price. Horrifyingly, the world is not expected to reach herd immunity until 2024 under this regime.
The WTO DG has said that current annual global COVID vaccine production capacity is 3.5 billion doses. But between 10-16 billion are needed to reach herd immunity, assuming 70% of population vaccination levels and some vaccines being two-shot regimes. There is no option but to create significantly more production capacity, especially given the prospect that these will not be one-time shots but perhaps needed on an ongoing basis if, like flu vaccines, they must be repeated or if booster shots have to be given.
The role of the WTO and its DG should be to facilitate negotiations among WTO member nations to fix the problem that is caused by existing WTO rules on intellectual property. Many health and vaccine-specific agencies already have initiatives underway that have failed to coax vaccine originator firms to license or otherwise share their technology. And, not one firm has participated in the World Health Organization's voluntary COVID-19 Technology Access Pool (C-TAP). Various global and even national agencies are better suited than the WTO to play matchmaker between originators and prospective manufacturers.
But missed connections are not the issue: Until policies change so vaccine originating firms do not have total control over production, such as a WTO TRIPS waiver and related government actions to pressure for tech transfers, supplies of vaccines and treatments will remain short. Many qualified firms in developing nations have sought licenses or contract manufacturing deals. Instead of agreeing to boost global production, vaccine originators have used their IP monopolies to effectively block production to supply markets they consider unprofitable. Their focus is not on global access. Consider Pfizer's investor relations VP's recent announcement that the firm will shift production next year to boosters for sale to rich nations at higher prices.
Had the TRIPS waiver of some WTO Trade Related Aspects of Intellectual Property (TRIPS) been agreed when proposed last year, perhaps more than 27% of people in low- and middle- income countries (LMICs) would be projected to get vaccines in 2021. Instead, few will have access until 2022. Many will wait until 2024. The pandemic will rage largely unmitigated among more than three quarters of the world's population.
A temporary TRIPS waiver can make sure "trade" rules are not an obstacle to countries' efforts to protect their residents' health and crush the pandemic. Indeed, the agreement establishing the WTO does not provide authority for the DG to broker deals between private firms. This activity is simply outside of its mandate.
In contrast, negotiating waivers of the obligations contained in WTO agreements due to the development of exceptional circumstances is an explicitly authorized function of the organization. If the COVID-19 pandemic does not constitute such exceptional circumstances, it is unclear what would qualify as such.
Today more than 100 WTO members support the waiver and consider it critical to boost worldwide production of COVID vaccines, treatments and diagnostic tests. Many hoped that the arrival of new WTO DG, economist Ngozi Okonjo-Iweala, might move countries currently blocking the waiver. Because South Africa introduced it and the WTO Africa Group supports it unanimously, some WTO members and activists worldwide hoped that the first African WTO DG could help facilitate progress. However, Okonjo-Iweala did not endorse the waiver. Instead, she diverted attention away from it by suggesting a "third way" that is more of what has failed.
Namely, corporations determine where and how much vaccines and other drugs are produced through highly restrictive voluntary licenses and contract manufacturing arrangements, with the monopoly-holding firms deciding if, how much, where and under what terms chosen partners may produce. One example of what the WTO DG proposes is South African firm Aspen's contract manufacturing arrangement with Johnson & Johnson (J&J). According to South Africa's WTO Counselor, for many months 91% of doses produced in South Africa had to be sent for sale in Europe, while only 9% could be used in South Africa.
Many pharmaceutical industry interests oppose the waiver and have a litany of arguments intended to redirect attention away from the core problem of their monopoly control over supply. They claim developing country firms cannot make these vaccines, even as they make limited contracts for such firms to do so. They claim that IP barriers are not a real obstacle to greater production. If IP was not an obstacle, manufacturers all over the world would already have begun to organize more production to fill the chasm between supply and demand. Instead, there are a limited number of market-segmented contract manufacturing arrangements, as determined by developers who restrict access to the technology. Moderna declined to partner with a qualified Bangladeshi vaccine maker while other firms report never getting any response to their inquiries. Just in Africa, "Biovac and Aspen in South Africa, Institute Pasteur in Senegal, and Vacsera in Egypt could rapidly retool factories to make mRNA vaccines," notes a group of medicine-production experts in a recent Foreign Policy article. Indeed, while COVID-19 shone a spotlight on the mRNA platform, for two decades researchers around the world have attempted to harness it for vaccines and therapies. A former Moderna director of chemistry revealed that with enough technology transfer and knowhow-sharing, a modern factory should be able to get mRNA vaccine production online in three to four months. The result of the originators' unwillingness to partner is a huge gap between needed global supply and the production levels that vaccine developers deem useful for their business strategy, which is focused mostly on selling at higher prices to rich and upper-middle-income countries.
Failure to enact a waiver in the face of this unprecedented health and economic crisis could be the final blow that dooms the WTO. The existential and intensifying crisis that has wracked the WTO in recent years is in no small part a consequence of the organization getting involved in or being used to dealing with issues clearly outside of its mandate. And the WTO's increasing irrelevance is related to the body not succeeding in managing problems and concerns that are directly in its remit.
The "third way" approach would double down on the same mistakes. By not prioritizing the negotiation of waiver language agreeable to all WTO member countries and desperately needed to address THE priority concern of many, the organization will become more irrelevant, while also alienating 100-plus countries that support the TRIPS waiver. If the new DG pulls the WTO -- an organization devised to negotiate and administer rules -- into instead pretending to become an international deal broker, it will only amplify concerns about the WTO staff and structures overstepping the authorities provided by member countries.
The way forward at the WTO is clear. Existing WTO rules are obstacles to scaling up global production and thus facilitating more equitable distribution of affordable, safe and effective COVID-19 vaccines, treatments and tests. Eliminating these obstacles is not the final step to greater production, but the first, so there is no time to waste. The DG's priority should be to pave a quick path to countries engaging in text-based negotiations on a waiver. If some WTO member countries have specific concerns with the waiver that South Africa and India have proposed, then the way forward is to offer changes to that proposal. Facilitating negotiations among WTO members to fix a problem caused by existing WTO rules, by preparing a waiver text that can be approved by all at the WTO General Council, is precisely the role of the DG and the WTO.
Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people - not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.
(202) 588-1000LATEST NEWS
Slotkin Panned Online After Claiming That Voters Don't Know What 'Oligarchy' Means
"It's condescending to say that the median person doesn't understand what oligarchy is," said one progressive strategist. "They're living it."
Apr 25, 2025
U.S. Sen. Bernie Sanders' tour headlined with this word has drawn more than 107,000 Americans in blue and deep-red states alike. Former President Joe Biden's use of it in his farewell speech prompted a spike in Google searches. And one recent poll found that a majority of U.S. voters, including 54% of Democrats and more than two-thirds of Independents, know exactly what it means.
Yet Sen. Elissa Slotkin (D-Mich.) was among the Democratic politicians insisting this week that no one does.
The word is "oligarchy"—a government ruled by a small group of elites—and as experts have warned for years, the U.S. increasingly resembles one. As Sanders (I-Vt.) and Rep. Alexandria Ocasio-Cortez (D-N.Y.) have told huge crowds in places like Nampa, Idaho and Greeley, Colorado in recent weeks, President Donald Trump's alliance with billionaire tech mogul Elon Musk has made the country's shift even more obvious.
But even as evidence mounts that Americans understand that the political system has been captured by corporations and the wealthiest people—and are living their day-to-day lives with the results, including higher healthcare costs and disinvestment in public services—Slotkin toldPolitico on Thursday that Democrats should "stop using the term 'oligarchy,' a phrase she said doesn't resonate beyond coastal institutions."
On Bluesky, The Nation writer John Nichols said that the tens of thousands people who have packed stadiums and parks in recent weeks to hear Sanders and Ocasio-Cortez speak would disagree with Slotkin.
Michigan Senator Elissa Slotkin says Democrats should stop using the term "oligarchy" because, she says, no one knows what it means. These people say she’s wrong.
[image or embed]
— John Nichols (@nicholsuprising.bsky.social) April 24, 2025 at 8:00 PM
Slotkin's advice for Democrats, which she dubbed her "war plan" and gave ahead of several speeches she has planned, also included a call for the party to stop being "weak and woke," phrases she said she heard in Michigan focus groups.
Her comments echoed those of former Chicago Mayor Rahm Emanuel, a longtime Democratic operative who told California Gov. Gavin Newsom on his podcast last week that using terms like "oligarchs" and "special interests" makes Democrats "worse marketers"; Newsom appeared to agree that people don't "understand" what an oligarchy is.
Emanuel also appeared on the political and pop culture podcast "I've Had It," hosted by Jennifer Welch and Angie Sullivan, and seemed caught of guard when Welch took him to task for his suggestion that Democrats should end their advocacy for issues that affect transgender Americans.
"That is total bullshit, that is buying into the right-wing media narrative, and I'm so sick of Democrats like you selling out and saying this," said Welch. "You know who talks about trans people more than anybody? MAGA... We've got to fucking fight. They're the gender-obsessed weirdos, not us. We're the ones who fight for Social Security, we fight for Medicare, and yeah, we're not gonna bully trans people."
Semafor political reporter Dave Weigel said Emanuel's derision of the word "oligarchy" is a clear "shot at Sanders/AOC, who keep saying it."
At one stop on the Fighting Oligarchy Tour recently, Sanders told a crowd that the enthusiasm for his and Ocasio-Cortez's message is "scaring the hell out of" Trump and Musk.
But shortly after Slotkin's comments, Ocasio-Cortez remarked—without naming the senator—that "plenty of politicians on both sides of the aisle feel threatened by rising class consciousness."
Angelo Greco, a progressive strategist who works with grassroots organizations including Our Revolution and One Fair Wage, told Common Dreams on Friday that establishment Democrats' dismissal of the term oligarchy is "out of touch" and "underestimates" voters.
"Tell me that farmers don't understand what the oligarchy is when there's a consolidation of the agribusiness that impacts them. Tell me that workers in Michigan don't understand what it means when trade deals that are written by multinational corporations have led to lower wages and plant closures," said Greco. "It's condescending to say that the median person doesn't understand what oligarchy is. They're living it."
Keep ReadingShow Less
'Fascism Getting Turned Up' as Trump FBI Arrests Wisconsin County Judge
"This isn't justice," said one observer. "It's a warning shot: Obey, or get cuffed."
Apr 25, 2025
This is a breaking story... Please check back for possible updates...
Federal agents arrested a sitting Wisconsin judge on Friday, accusing her of helping an undocumented immigrant evade arrest after he appeared in her courtroom last week, FBI Director Kash Patel said on social media.
In a since-deleted post, Patel said the FBI arrested 65-year-old Milwaukee County Circuit Judge Hannah Dugan "on charges of obstruction."
"We believe Judge Dugan intentionally misdirected federal agents away from the subject to be arrested in her courthouse... allowing the subject—an illegal alien—to evade arrest," Patel wrote. "Thankfully, our agents chased down the perp on foot and he's been in custody since, but the judge's obstruction created increased danger to the public."
FBI arrests judge in escalation of Trump immigration enforcement effort Federal agents arrested Milwaukee Circuit Court Judge Hannah Dugan on obstruction charges. Dugan is accused of “helping” an immigrant evade arrest. The fascism getting turned up!
[image or embed]
— RootsAction (@rootsaction.org) April 25, 2025 at 8:05 AM
It is unclear why Patel deleted the post. U.S. Marshals Service spokesperson Brady McCarron and multiple Milwaukee County judges confirmed Dugan's arrest, according to the Milwaukee Journal Sentinel. McCarron said Dugan is facing two federal felony counts: obstruction and concealing an individual.
The Journal Sentinel reported that Dugan "appeared before U.S. Magistrate Judge Stephen C. Dries during a brief hearing in a packed courtroom at the federal courthouse after her arrest. Dugan, who was wearing a black dress with white flowers, made no public comments during the brief hearing."
Dugan's attorney, Craig Mastantuono, told the court that "Judge Dugan wholeheartedly regrets and protests her arrest," which "was not made in the interest of public safety."
Responding to Dugan's arrest, liberal podcaster Brian Allen wrote on social media: "This isn't justice. It's a warning shot: Obey, or get cuffed."
Keep ReadingShow Less
ICE Admits They Didn't Have a Warrant When They Arrested Mahmoud Khalil
"ICE has admitted it detained Mahmoud illegally and without a warrant—to justify it, they are now flat out lying with an absurd claim that he tried to flee," said a staff attorney at the Center for Constitutional Rights.
Apr 25, 2025
U.S. Immigration and Customs Enforcement agents did not have a warrant when they arrested Palestinian activist and green-card holder Mahmoud Khalil on March 8, according to court papers filed by the Department of Homeland Security on Thursday—an admission that elicited outrage from members of Khalil's legal team.
Marc Van Der Hout, an attorney representing Khalil, said Thursday that "DHS agents who arrested Mahmoud lied to him: They wrote in their arrest report that the agents told him that they had an arrest warrant, but DHS has now admitted in their filing that that was a lie and that there was no warrant at all at the time of the arrest."
"The government's admission is astounding," added Van Der Hout.
Officers with DHS served Khalil with a warrant after his arrest when he arrived at an ICE facility in New York for processing, according to court filings. In the filing, an attorney for DHS argued that "an exception to the warrant requirement exists where the immigration officer has reason to believe that the individual is likely to escape before a warrant can be obtained."
According to the government, immigration agents did not need a warrant to arrest Khalil because his conduct gave them reason to believe it was likely he would flee. The government also alleged that Khalil "refused to cooperate" with immigration agents arresting him—an account that Khalil's supporters say contradicts a video of his arrest that was taken by his wife, Noor Abdalla.
"ICE has admitted it detained Mahmoud illegally and without a warrant—to justify it, they are now flat out lying with an absurd claim that he tried to flee. At every step of the way, the Trump administration has flouted the law," said Samah Sisay, a staff attorney at the Center for Constitutional Rights.
Another attorney for Khalil, Amy Greer, said she was on the phone with Khalil, his wife, and even spoke to the agent making the arrest on March 8.
"In the face of multiple agents in plain clothes who clearly intended to abduct him, and despite the fact that those agents repeatedly failed to show us a warrant, Mahmoud remained calm and complied with their orders," she said Thursday. "Today we now know why they never showed Mahmoud that warrant—they didn't have one."
According to CNN, these latest documents were filed to fulfill a request from the New Jersey federal district court judge overseeing Khalil's federal case, who directed Khalil's legal team and attorneys at the Department of Justice to submit all filings that were presented in his immigration case in Louisiana, where he is currently being held at an ICE detention center.
In federal court, Khalil's attorneys are challenging the legality of his detention and have sought his release on bail.
Khalil, who completed work on his masters degree from Columbia University in December, was active in pro-Palestine organizing on the school's campus last year. Another Palestinian green-card holder active in Columbia's student protest movement, Mohsen Mahdawai, was also recently arrested by federal immigration agents.
Abdalla was eight months pregnant when Khalil was detained. ICE denied Kahlil's request for a temporary furlough to be with his wife while she gave birth on April 21.
Keep ReadingShow Less
Most Popular